查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2102806

獸藥市場：全球市場預測，2026-2032年

Livestock Medicine Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，畜牧藥品市場規模將達到 307.2 億美元，年複合成長率為 5.71%。

主要市場統計數據
基準年 2025 208.2億美元
預計年份：2026年 219.5億美元
預測年份 2032 307.2億美元
複合年成長率 (%) 5.71%

隨著生產者、獸醫、監管機構和食品鏈相關人員共同應對日益成長的安全動物蛋白需求、跨境動物疫病的持續風險、抗生素抗藥性以及氣候變遷對畜禽養殖業帶來的壓力，獸醫學正成為支撐畜牧業韌性發展的重要戰略支柱。此領域涵蓋牛、豬、家禽、綿羊、山羊和水產養殖相關生產系統中的醫療保健、疫苗、驅蟲藥、感染疾病物、診斷、生殖健康、營養療法、生物安全以及畜群健康管理。全球動物衛生機構檢驗的公共衛生指南始終強調，預防、監測、疫苗接種、合理使用抗生素以及快速應對疫情是保護動物福利和食品安全的關鍵。在此背景下，獸醫學正從孤立的治療轉向以診斷、數位化記錄、農場層面監測和更強力的獸醫監管為支撐的、基於循證醫學的綜合畜群醫學。

獸醫學領域的變革性變化

獸醫學的格局正受到四大關鍵因素的重塑：疾病威脅、監管現代化、永續性預期和數位轉型。禽流感、非洲豬瘟、口蹄疫、結節性皮膚炎以及地方性呼吸道和腸道感染疾病的爆發，持續凸顯疫苗接種、監測和生物安全的重要性。同時，許多地區正在加強合理使用抗菌藥物（AMS）政策，鼓勵獸醫和生產者實施基於診斷的治療、改進的牲畜管理、疫苗接種計劃以及減少不必要抗生素暴露的替代方案。食品零售商、加工商和出口市場也更重視可追溯性、動物福利、殘留物管理和環境績效。這些變化正在加速對綜合畜群健康管理方案、可靠的生技藥品低溫運輸、即時診斷、疾病監測系統以及兼顧生產力、公共衛生和永續性目標的預防醫學方案的需求。

人工智慧對畜牧醫學的累積影響

人工智慧 (AI) 正在改變獸醫服務的提供方式，尤其是在疾病檢測、精準治療、生物安全監測和獸醫決策支援方面。 AI 驅動的影像識別、聲學監測、穿戴式感測器和電腦視覺技術可以幫助識別跛行、呼吸窘迫、熱壓力、異常採食行為和繁殖問題的早期徵兆，從而在臨床損失加劇之前進行干預。預測分析可以整合獸醫記錄、天氣數據、遷徙數據、生產指標和實驗室結果，以識別畜群層面的疾病風險並指導有針對性的干預措施。 AI 還可以透過協助獸醫評估治療史、藥敏試驗結果、藥物停用情況和復發模式來支持合理使用抗菌藥物 (AMS)。然而，AI 的應用取決於數據品質、互通性、農場連接性、網路安全、獸醫資格和倫理管治。人工智慧在輔助而非取代臨床決策時才能發揮最大價值，從而實現更早的干預、更強力的監測以及更有效地利用疫苗、診斷和治療方法。

畜牧醫學的關鍵區域見解

亞太地區是動物健康的重要中心，這得益於其規模龐大且多樣化的動物蛋白生產體系，涵蓋集約化家禽和生豬養殖、小規模酪農以及多元化農業等。該地區反覆面臨禽流感、豬病、寄生蟲感染疾病和通用感染疾病等問題的壓力，因此疫苗接種、診斷、生物安全和獸醫服務是重中之重。北美地區擁有先進的獸醫基礎設施、強力的法律規範、完善的畜群健康管理體系，並廣泛應用診斷、疫苗、處方動物用藥品和數位化生產記錄，合理使用抗生素和可追溯性是該地區採購和治療實踐的關鍵所在。拉丁美洲仍然是牛、家禽和生豬生產的重要地區，巴西和墨西哥對符合出口標準的疾病預防、寄生蟲控制、生殖健康和殘留物管理的需求日益成長。在歐洲，嚴格的食品安全和動物醫藥法規是保障動物福利、減少抗生素依賴、藥物安全監測和預防性獸醫的重要保障。在中東，糧食安全、高價值乳製品、家禽、駱駝和小反芻動物的健康是優先事項，而熱壓力、對進口的依賴和生物安全問題則影響獸藥和服務的需求。在非洲，商業性畜牧業的擴張與對小規模農戶的依賴並存，動物健康與糧食安全、農村生計、疫苗宣傳活動、寄生蟲控制以及獸醫診斷技術和低溫運輸配送的改善密切相關。

畜牧醫學中的關鍵群體特定見解

東協畜牧業醫療保健的優先事項受到高密度家禽和生豬養殖、小規模農業、熱帶疾病威脅以及加強跨境價值鏈監測和生物安全的需求等因素的影響。海灣合作理事會（GCC）國家優先考慮支持糧食安全、集約化乳牛和家禽養殖系統、駱駝和小反芻動物健康以及適應高溫壓力和缺水環境的獸醫解決方案。歐盟透過對獸藥、抗生素使用、動物福利、殘留監測和「從農場到餐桌」安全方面的嚴格監管，持續影響全球畜牧業醫療保健標準，並推廣預防醫學和採用有據可查的治療方案。金磚國家畜牧業存欄量大規模，動物性蛋白質消費量不斷成長，且疾病管理需求迫切，因此將管治、驅蟲藥、診斷技術和畜群健康服務置於提高生產力和增強韌性的核心地位。七國集團在獸醫治理水準、先進的診斷技術、監測系統、合理使用抗生素和創新應用方面表現突出，並高度重視與「同一健康」理念的契合。北約成員國的畜牧系統各不相同，但越來越關注供應鏈韌性、生物安全、糧食安全和疾病控制，尤其是在農業永續性和國家韌性計畫交叉的領域。

主要國家對獸醫學的見解

美國擁有高度發展的動物保健體系，這得益於大規模的牛、豬、家禽和乳牛業務、動物醫藥處方監管、疾病監測以及數位化畜群健康管理工具的廣泛應用。加拿大強調生物安全、合理使用抗生素、乳牛和肉牛牛群健康，以及貫穿整個一體化生產鏈的嚴格食品安全合規性。墨西哥的動物保健重點包括牛和家禽健康、疫苗接種、寄生蟲控制和貿易相關疾病監測。巴西是動物性蛋白質的主要生產國，其動物保健與牛肉、家禽、豬、繁殖性能、地方性疾病控制以及出口市場合規性密切相關。英國在動物福利、獸醫監管、殘留物控制和合理使用抗生素方面保持著高標準，而德國和法國則專注於規範的動物醫藥使用、預防性動物健康管理、診斷和食品鏈安全。俄羅斯的動物保健需求主要受大規模家禽、豬和牛生產體系、疾病預防和國家糧食安全優先事項的驅動。在義大利和西班牙，集約化畜牧業與嚴格的歐洲獸醫法規相結合，支撐了對疫苗、生物安全和符合動物福利標準的治療的需求。中國擁有以豬、家禽、乳牛和水產養殖為主的密集蛋白質生產體系，是動物保健轉型的主要動力，尤其注重疾病管制、疫苗接種和生物安全，以應對大規模動物疫病造成的衝擊。印度的動物醫藥格局受到全球規模最大的乳牛養殖戶群體之一、小規模農戶生產、疫苗接種計劃、寄生蟲病管理以及日益成長的獸醫服務需求的影響。日本優先發展生物安全、食品安全、可追溯性和先進獸醫服務的畜牧系統，而澳洲則強調以牧場為基礎的牛養殖、無疫狀態、寄生蟲控制和出口保障。韓國畜牧保健的重點包括高密度養豬和家禽養殖、快速疾病應變、疫苗接種和技術驅動的農場監測。

為獸醫學領導者提供的實用建議

行業領導者應優先考慮預防性畜牧保健策略，將其作為涵蓋疫苗接種、診斷、寄生蟲控制、育種管理、營養管理和生物安全的綜合畜群保健計劃。獸醫工作應支持基於診斷的治療、藥敏試驗、遵守停藥期，並根據合理使用抗生素的政策，尋找減少不必要抗生素暴露的替代方案。投資於低溫運輸完整性、確保供應鏈末端的獸醫服務以及對農場工人進行培訓，可以改善結果，尤其是在生產系統分散的地區。應在能夠提供可衡量的臨床價值的領域使用數位化工具，例如早期疾病檢測、治療記錄、可追溯性和福利監測。領導者還需要加強藥物安全監測、法規遵循和殘留物控制系統，以確保食品安全和出口應對力。與獸醫、生產者組織、實驗室、大學和公共機構的合作可以加強監測系統，提高應對感染疾病疫情的準備能力，並加速推廣實證畜牧保健實踐。

調查方法

本執行摘要採用以二手資料研究為主導的指南撰寫，檢驗關注來自公共獸醫機構、動物衛生監管機構、食品安全機構、同行評審的科學文獻、農業政策資訊來源以及國際公認的「一體化健康」主導的經核實且有數據支持的資訊。分析著重於對疾病動態、監管方向、合理使用抗菌藥物、動物福利標準、技術應用以及區域畜牧業特徵的定性評估。資訊來源的可靠性、時效性、調查方法的透明度以及與不同物種和地區動物健康的相關性均經過評估。本方法有意排除市場規模、市場佔有率和預測，而是著重於基於證據的促進因素、限制因素、區域趨勢以及對產業決策者的策略意義。

結論

獸醫學正朝著更加重視預防、數據驅動和負責任使用的時代邁進。疾病防範、疫苗接種、診斷、合理使用抗生素、動物福利和可追溯性如今已成為畜牧業生產力和食品系統韌性的核心要素。各地區的優先事項有所不同，例如歐洲和北美地區高度重視監管合規，而亞太地區、拉丁美洲、非洲和中東地區則更注重提高醫療服務可近性和疾病控制需求。人工智慧和數位監測，結合經過檢驗的數據和實際的現場工作流程，可以增強獸醫的決策能力。那些將「同一健康」原則、生物安全、監管合規和生產者層面的便利性融入其畜牧醫學策略的機構，將更有能力支持更健康的動物、更安全的食品和更具韌性的農業系統。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：獸藥市場：依產品類型分類

  • 抗發炎藥
  • 抗生素
    • 頭孢菌素
    • 青黴素類
    • 四環黴素
  • 殺蟲劑
    • 體外寄生蟲控制劑
    • 體內寄生蟲控制劑
  • 飼料添加劑
    • 益生元
    • 益生菌
  • 荷爾蒙
    • 生長激素
    • 生殖荷爾蒙
  • 疫苗
    • 去活化疫苗
    • 減毒活疫苗
    • 次單位疫苗

第8章：獸藥市場：依疾病類型分類

  • 感染疾病
  • 代謝性疾病
  • 營養缺乏症
  • 寄生蟲病
  • 生殖疾病

第9章：獸藥市場：依動物類型分類

  • 水產養殖
  • 牛
  • 山羊
  • 家禽
  • 羊
  • 豬

第10章：獸藥市場：依劑型分類

  • 膠囊
  • 凝膠
  • 液體
  • 粉末
  • 藥片

第11章：獸藥市場：依給藥途徑分類

  • 吸入
  • 注射藥物
    • 肌肉內部
    • 靜脈
  • 口服
    • 液體
    • 藥片
  • 外用
    • 奶油
    • 修補

第12章：獸藥市場：依最終用戶分類

  • 畜牧業的棋子
  • 動物診所
  • 動物醫院

第13章：獸藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：獸藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：獸藥市場：依國家分類

  • 美國
  • 德國
  • 中國
  • 英國
  • 印度
  • 日本
  • 俄羅斯
  • 巴西
  • 加拿大
  • 義大利
  • 墨西哥
  • 法國
  • 西班牙
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • AdvaCare Pharma USA
  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Bimeda Holdings Limited
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories SA
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • HESTER BIOSCIENCES LIMITED
  • HIPRA SA
  • HUVEPHARMA EOOD
  • Indian Immunologicals Ltd.
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Group
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Vetpro Healthcare
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-FE3E5C0AE72F

The Livestock Medicine Market is projected to grow by USD 30.72 billion at a CAGR of 5.71% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.82 billion
Estimated Year [2026] USD 21.95 billion
Forecast Year [2032] USD 30.72 billion
CAGR (%) 5.71%

Livestock medicine is becoming a strategic pillar of resilient animal agriculture as producers, veterinarians, regulators, and food-chain stakeholders respond to rising demand for safe animal protein, persistent transboundary animal disease risks, antimicrobial resistance, and climate-related stress on herds and flocks. The field spans preventive healthcare, vaccines, parasiticides, anti-infectives, diagnostics, reproductive health, nutritional therapeutics, biosecurity, and herd health management across cattle, swine, poultry, sheep, goats, and aquaculture-adjacent production systems. Verified public-health guidance from global animal health authorities consistently emphasizes prevention, surveillance, vaccination, responsible antimicrobial use, and rapid outbreak response as essential to protecting animal welfare and food security. In this environment, livestock medicine is shifting from episodic treatment toward integrated, evidence-led population medicine, supported by diagnostics, digital records, farm-level monitoring, and stronger veterinary oversight.

Transformative Shifts in the Livestock Medicine Landscape

The livestock medicine landscape is being reshaped by four major forces: disease pressure, regulatory modernization, sustainability expectations, and digital transformation. Outbreaks of avian influenza, African swine fever, foot-and-mouth disease, lumpy skin disease, and endemic respiratory and enteric infections continue to reinforce the value of vaccination, surveillance, and biosecurity. At the same time, antimicrobial stewardship policies are tightening across many jurisdictions, encouraging veterinarians and producers to adopt diagnostics-led treatment, improved husbandry, vaccination programs, and alternatives that reduce unnecessary antimicrobial exposure. Food retailers, processors, and export markets are also placing greater emphasis on traceability, animal welfare, residue control, and environmental performance. These shifts are accelerating demand for integrated herd health programs, cold-chain reliability for biologics, point-of-care diagnostics, disease monitoring systems, and preventive medicine protocols that align productivity with public health and sustainability goals.

Cumulative Impact of Artificial Intelligence on Livestock Medicine

Artificial intelligence is beginning to alter how livestock medicine is delivered, particularly in disease detection, precision treatment, biosecurity monitoring, and veterinary decision support. AI-enabled image recognition, acoustic monitoring, wearable sensors, and computer vision can help identify early signs of lameness, respiratory distress, heat stress, abnormal feeding behavior, and reproductive events before clinical losses escalate. Predictive analytics can combine veterinary records, weather data, movement data, production metrics, and laboratory results to flag herd-level disease risks and guide targeted interventions. AI also supports antimicrobial stewardship by helping veterinarians evaluate treatment histories, susceptibility results, withdrawal periods, and recurrence patterns. However, adoption depends on data quality, interoperability, farm connectivity, cybersecurity, veterinary validation, and ethical governance. The greatest value is expected where AI augments rather than replaces clinical judgment, enabling earlier intervention, stronger surveillance, and more efficient use of vaccines, diagnostics, and therapeutics.

Key Regional Insights Across Livestock Medicine

Asia-Pacific is a critical center for livestock medicine due to its large and diverse animal protein systems, ranging from intensive poultry and swine operations to smallholder dairy and mixed farming. The region faces recurring pressure from avian influenza, swine diseases, parasitic infections, and zoonotic disease concerns, making vaccination, diagnostics, biosecurity, and veterinary access central priorities. North America is characterized by advanced veterinary infrastructure, strong regulatory oversight, established herd health programs, and broad use of diagnostics, vaccines, prescription animal medicines, and digital production records, with antimicrobial stewardship and traceability shaping purchasing and treatment practices. Latin America remains highly important for cattle, poultry, and swine production, with Brazil and Mexico reinforcing demand for disease prevention, parasite control, reproductive health, and export-compliant residue management. Europe places strong emphasis on animal welfare, reduced antimicrobial dependence, pharmacovigilance, and preventive veterinary medicine, supported by strict food-safety and veterinary medicine regulations. The Middle East prioritizes food security, high-value dairy, poultry, camel, and small ruminant health, with heat stress, import dependence, and biosecurity influencing veterinary product and service needs. Africa presents a dual landscape of commercial livestock expansion and smallholder dependence, where livestock medicine is closely tied to food security, rural livelihoods, vaccination campaigns, parasite control, and improved access to veterinary diagnostics and cold-chain distribution.

Key Group Insights Across Livestock Medicine

ASEAN livestock medicine priorities are shaped by dense poultry and swine production, smallholder farming, tropical disease pressure, and the need for stronger surveillance and biosecurity across cross-border value chains. GCC countries emphasize veterinary solutions that support food security, intensive dairy and poultry systems, camel and small ruminant health, and adaptation to heat stress and water scarcity. The European Union continues to influence global livestock medicine standards through stringent rules on veterinary medicinal products, antimicrobial use, animal welfare, residue monitoring, and farm-to-fork safety, encouraging preventive care and documented treatment protocols. BRICS economies combine large livestock populations, expanding animal protein consumption, and significant disease-management needs, making vaccines, anti-parasitics, diagnostics, and herd health services central to productivity and resilience. G7 countries are prominent in high-standard veterinary governance, advanced diagnostics, surveillance systems, antimicrobial stewardship, and innovation adoption, with strong emphasis on One Health alignment. NATO member states, while diverse in livestock systems, share heightened attention to supply-chain resilience, biosecurity, food security, and disease preparedness, particularly where agricultural continuity intersects with national resilience planning.

Key Country Insights Across Livestock Medicine

The United States has a highly developed livestock medicine ecosystem supported by large-scale cattle, swine, poultry, and dairy operations, veterinary prescription oversight, disease surveillance, and growing adoption of digital herd health tools. Canada emphasizes biosecurity, responsible antimicrobial use, dairy and beef herd health, and strong food-safety compliance across integrated production chains. Mexico's livestock medicine priorities include cattle and poultry health, vaccination, parasite control, and trade-linked disease monitoring. Brazil is a major animal protein producer where livestock medicine is closely tied to beef, poultry, swine, reproductive performance, endemic disease control, and export-market compliance. The United Kingdom maintains strong standards in animal welfare, veterinary oversight, residue control, and antimicrobial stewardship, while Germany and France place strong emphasis on regulated veterinary medicine use, preventive livestock health, diagnostics, and food-chain safety. Russia's livestock medicine needs are influenced by large poultry, swine, and cattle production systems, disease prevention, and domestic food security priorities. Italy and Spain combine intensive livestock production with strict European veterinary regulations, supporting demand for vaccines, biosecurity, and animal welfare-compliant treatment. China is a major driver of livestock health transformation due to intensive swine, poultry, dairy, and aquaculture-linked protein systems, with strong focus on disease control, vaccination, and biosecurity after major animal disease disruptions. India's livestock medicine landscape is shaped by one of the world's largest dairy animal bases, smallholder production, vaccination programs, parasitic disease management, and growing veterinary access needs. Japan prioritizes high-biosecurity livestock systems, food safety, traceability, and advanced veterinary care, while Australia emphasizes extensive cattle and sheep production, disease freedom status, parasite management, and export assurance. South Korea's livestock medicine priorities include high-density swine and poultry production, rapid disease response, vaccination, and technologically enabled farm monitoring.

Actionable Recommendations for Livestock Medicine Leaders

Industry leaders should prioritize preventive livestock healthcare strategies that combine vaccination, diagnostics, parasite control, reproductive management, nutrition, and biosecurity into integrated herd and flock health programs. Veterinary medicine portfolios should align with antimicrobial stewardship by supporting diagnostics-led treatment, susceptibility testing, withdrawal-period compliance, and alternatives that reduce avoidable antimicrobial exposure. Investment in cold-chain integrity, last-mile veterinary access, and training for farm personnel can improve outcomes, especially in regions with fragmented production systems. Digital tools should be adopted where they provide measurable clinical value, such as early disease detection, treatment documentation, traceability, and welfare monitoring. Leaders should also strengthen pharmacovigilance, regulatory compliance, and residue-management systems to support food safety and export readiness. Collaboration with veterinarians, producer groups, laboratories, universities, and public agencies can enhance surveillance, improve outbreak preparedness, and accelerate adoption of evidence-based livestock medicine practices.

Research Methodology

This executive summary is developed through a secondary research-led methodology focused on verified, data-backed information from public veterinary authorities, animal health regulators, food-safety agencies, peer-reviewed scientific literature, agricultural policy sources, and internationally recognized One Health guidance. The analysis emphasizes qualitative assessment of disease dynamics, regulatory direction, antimicrobial stewardship, animal welfare standards, technology adoption, and regional livestock production characteristics. Sources are evaluated for credibility, recency, methodological transparency, and relevance to livestock medicine across species and geographies. The approach intentionally excludes market sizing, market share, and forecasting, focusing instead on evidence-based drivers, constraints, regional patterns, and strategic implications for industry decision-makers.

Conclusion

Livestock medicine is entering a more preventive, data-enabled, and stewardship-driven era. Disease preparedness, vaccination, diagnostics, responsible antimicrobial use, animal welfare, and traceability are now central to livestock productivity and food-system resilience. Regional priorities differ, from high-standard regulatory compliance in Europe and North America to access expansion and disease-control needs across Asia-Pacific, Latin America, Africa, and the Middle East. Artificial intelligence and digital monitoring can strengthen veterinary decision-making when grounded in validated data and practical farm workflows. Organizations that align livestock medicine strategies with One Health principles, biosecurity, regulatory compliance, and producer-level usability will be best positioned to support healthier animals, safer food, and more resilient agricultural systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Livestock Medicine Market, by Product Type

  • 7.1. Introduction
  • 7.2. Anti-inflammatory Agents
  • 7.3. Antibiotics
    • 7.3.1. Cephalosporins
    • 7.3.2. Penicillins
    • 7.3.3. Tetracyclines
  • 7.4. Antiparasitic Agents
    • 7.4.1. Ectoparasiticides
    • 7.4.2. Endoparasiticides
  • 7.5. Feed Additives
    • 7.5.1. Prebiotics
    • 7.5.2. Probiotics
  • 7.6. Hormones
    • 7.6.1. Growth Hormones
    • 7.6.2. Reproductive Hormones
  • 7.7. Vaccines
    • 7.7.1. Inactivated Vaccines
    • 7.7.2. Live Attenuated Vaccines
    • 7.7.3. Subunit Vaccines

8. Livestock Medicine Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Infectious Diseases
  • 8.3. Metabolic Diseases
  • 8.4. Nutritional Deficiency Diseases
  • 8.5. Parasitic Diseases
  • 8.6. Reproductive Diseases

9. Livestock Medicine Market, by Animal Type

  • 9.1. Introduction
  • 9.2. Aquaculture
  • 9.3. Cattle
  • 9.4. Goats
  • 9.5. Poultry
  • 9.6. Sheep
  • 9.7. Swine

10. Livestock Medicine Market, by Formulation

  • 10.1. Introduction
  • 10.2. Capsules
  • 10.3. Gels
  • 10.4. Liquids
  • 10.5. Powders
  • 10.6. Tablets

11. Livestock Medicine Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Inhalation
  • 11.3. Injectable
    • 11.3.1. Intramuscular
    • 11.3.2. Intravenous
  • 11.4. Oral
    • 11.4.1. Liquids
    • 11.4.2. Tablets
  • 11.5. Topical
    • 11.5.1. Creams
    • 11.5.2. Patches

12. Livestock Medicine Market, by End Users

  • 12.1. Introduction
  • 12.2. Livestock Farmers
  • 12.3. Veterinary Clinics
  • 12.4. Veterinary Hospitals

13. Livestock Medicine Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Livestock Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Livestock Medicine Market, by Country

  • 15.1. United States
  • 15.2. Germany
  • 15.3. China
  • 15.4. United Kingdom
  • 15.5. India
  • 15.6. Japan
  • 15.7. Russia
  • 15.8. Brazil
  • 15.9. Canada
  • 15.10. Italy
  • 15.11. Mexico
  • 15.12. France
  • 15.13. Spain
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. AdvaCare Pharma USA
  • 17.2. Anicon Labor GmbH by SAN Group GmbH
  • 17.3. AniCura Group by Mars Petcare
  • 17.4. Bimeda Holdings Limited
  • 17.5. Biogenesis Bago SA
  • 17.6. Boehringer Ingelheim International GmbH
  • 17.7. Calier Laboratories S.A.
  • 17.8. Cargill, Incorporated
  • 17.9. Ceva Sante Animale
  • 17.10. Dechra Pharmaceuticals PLC
  • 17.11. Elanco Animal Health Incorporated
  • 17.12. HESTER BIOSCIENCES LIMITED
  • 17.13. HIPRA S.A.
  • 17.14. HUVEPHARMA EOOD
  • 17.15. Indian Immunologicals Ltd.
  • 17.16. Merck KGaA
  • 17.17. Neogen Corporation
  • 17.18. Norbrook Group
  • 17.19. Parnell Pharmaceuticals Holdings Ltd.
  • 17.20. Phibro Animal Health Corporation
  • 17.21. Vetoquinol S.A.
  • 17.22. Vetpharma Animal Health S.L.
  • 17.23. Vetpro Healthcare
  • 17.24. Virbac SA
  • 17.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIVESTOCK MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL LIVESTOCK MEDICINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL LIVESTOCK MEDICINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL LIVESTOCK MEDICINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-INFLAMMATORY AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-INFLAMMATORY AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTI-INFLAMMATORY AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CEPHALOSPORINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEPHALOSPORINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CEPHALOSPORINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIPARASITIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTIPARASITIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIPARASITIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PREBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PREBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PREBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GROWTH HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GROWTH HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GROWTH HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REPRODUCTIVE HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REPRODUCTIVE HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REPRODUCTIVE HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL METABOLIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL METABOLIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL METABOLIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUTRITIONAL DEFICIENCY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NUTRITIONAL DEFICIENCY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUTRITIONAL DEFICIENCY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REPRODUCTIVE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CREAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LIVESTOCK FARMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LIVESTOCK FARMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LIVESTOCK FARMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. GCC LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 264. GCC LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. GCC LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 271. GCC LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. G7 LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 305. G7 LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 306. G7 LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 307. G7 LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 309. G7 LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. G7 LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. G7 LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 312. G7 LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. G7 LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 314. G7 LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 316. G7 LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO LIVESTOCK MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 318. NATO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 321. NATO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. NATO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. NATO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 327. NATO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 328. NATO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 329. NATO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 330. NATO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 331. NATO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 332. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 348. GERMANY LIVESTOCK MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 351. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 352. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 358. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 359. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 360. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 361. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 362. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 363. CHINA LIVESTOCK MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 366. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 367. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 372. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 373. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 374. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 375. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 376. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 377. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 378. UNITED KINGDOM LIVESTOCK MEDICINE MARK